Glaukos (GKOS)
(Delayed Data from NYSE)
$122.60 USD
-2.68 (-2.14%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $122.65 +0.05 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Glaukos Corporation [GKOS]
Reports for Purchase
Showing records 121 - 127 ( 127 total )
Company: Glaukos Corporation
Industry: Medical - Instruments
ASCRS Takeaways Indicate Demand for iStent/MIGS Increasingly Strong
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
Eye Opening Beat and Raise to Start 2016 - Reiterate Buy
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
1Q Preview: 1Q Consensus Feels Light; ASCRS Meeting This Weekend
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
We are initiating coverage on Glaukos with a Buy rating and target price of $24.
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C